ALZHEON, INC.
FRAMINGHAM, MA · Founded 2013 · CIK 0001582636 · Biotech · Private
Small-molecule therapeutic drugs targeting Alzheimer's disease and neurological disorders
alzheon.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $134M
- 10 Form D · Sep 2026
- 1 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 8 granted · 32 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20122014201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $330,000 | |
| Private capital raised | Form D · SEC | $3,050,000 | |
| Private capital raised | Form D · SEC | $6,905,000 | |
| Private capital raised | Form D · SEC | $1,300,000 | |
| Private capital raised | Form D · SEC | $15,764,099 | |
| Private capital raised | Form D · SEC | $6,163,716 | |
| Private capital raised | Form D · SEC | $2,432,016 | |
| Private capital raised | Form D · SEC | $1,703,768 | |
| Private capital raised | Form D · SEC | $17,249,891 | |
| Private capital raised | Form D · SEC | $78,797,184 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1615 | Stratum Biosciences Inc. | — | $100K |
| 1616 | Generate Biomedicines | — | — |
| 1617 | Provizigen LLC | — | — |
| 1618 | ALZHEON, INC. | — | $134M |
| 1619 | Repair Biotechnologies, Inc. | — | $25M |
| 1620 | REELIN THERAPEUTICS, INC. | — | — |
| 1621 | DASFANH BIOSCIENCES, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Susan Abushakra, M.D.Executive Officer
- Michael AcetiExecutive Officer
- Adem AlbayrakExecutive Officer
- Menghis BairuDirector
- Franklin BergerDirector
- ADAM BROCKMANExecutive Officer
- Christopher DunnDirector
- Noel DunnDirector
- Neil FlanzraichDirector
- Jean-Pierre GarnierDirector
- Franz HeftiDirector
- Jordan HellerDirector
- John HeyExecutive Officer
- JOHN HEYExecutive Officer
- John Hey, Ph.D.Executive Officer
- Diane Jorkasky, M.D.Director
- Dennis LangerDirector
- Ken MaceExecutive Officer
- Kenneth MaceExecutive Officer
- GREGORY MILLERExecutive Officer
- Scott MinickDirector
- David NikodemDirector
- David Nikodem, Ph.D.Director
- Glenn PaulyExecutive Officer
- Aidan Power, MRCPsychExecutive Officer
- Gino SantiniDirector
- Muneer SateerDirector
- Muneer SatterDirector
- Robert SilvermanExecutive Officer
- Jean-Pierre SommadossiDirector
- Martin TolarDirector · Executive Officer
- MARTIN TOLARDirector · Executive Officer
- Martin Tolar, M.D., Ph.D.Director · Executive Officer
- Mark VersavelExecutive Officer
- MARK VERSAVELExecutive Officer
- JEREMY YUExecutive Officer
Patents
- Methods For Treating Neurodegenerative Disorders With Tramiprosateapplication
- Sulfopropanoic Acid Derivatives For Treating Neurodegenerative Disordersapplication
- APOE4 Correctors And Methods Of Useapplication
- Methods For Treating Neurodegenerative Disordersapplication
- Sulfopropanoic Acid Derivatives For Treating Neurodegenerative Disordersgranted
- ALZ-801 For Use In Treating A COVID-19 Associated Neurological Symptomapplication
- ALZ-801 For Use In Treating Alzheimer's Diseaseapplication
- Compositions And Methods For Treating And Preventing Neurodegenerative Disordersgranted
- Methods For Treating Neurodegenerative Disordersapplication
- Methods For Treating Neurodegenerative Disordersgranted
- Methods For Treating Neurodegenerative Disordersgranted
- Methods Of Treating Neurodegenerative Disorders In A Particular Populationapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.